Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mckenzie

Showing results (701-710 of 735) with videos related to

Pageof 74
Sort By:
Plos Genetics|March 12, 2010
Rapid assessment of genetic ancestry in populations of unknown origin by genome-wide genotyping of pooled samplesCharleston W K Chiang, Zofia K Z Gajdos, Joshua M Korn, et al.
Journal of the National Cancer Institute|December 22, 2017
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer ImmunotherapyJodi A McKenzie, Rina M Mbofung, Shruti Malu, et al.
Medicine|October 6, 2023
Sodium and potassium consumption in Jamaica: National estimates and associated factors from the Jamaica Health and Lifestyle Survey 2016-2017Trevor S Ferguson, Novie O M Younger-Coleman, Karen Webster-Kerr, et al.
BMJ Open|December 10, 2023
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UKTimothy Simon Walsh, Leanne M Aitken, Cathrine A McKenzie, et al.
Nature Communications|September 8, 2017
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genesRina M Mbofung, Jodi A McKenzie, Shruti Malu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2018
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A ExpressionLu Huang, Shruti Malu, Jodi A McKenzie, et al.
Health Technology Assessment (Winchester, England)|July 1, 2026
Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluationTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2020
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicitySimone Punt, Shruti Malu, Jodi A McKenzie, et al.
American Journal of Human Genetics|January 15, 2013
LRIG2 mutations cause urofacial syndromeHelen M Stuart, Neil A Roberts, Berk Burgu, et al.
JAMA|May 19, 2025
Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical TrialTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
Pageof 74

Showing results (701-710 of 735) with videos related to

Sort By:
Pageof 74
Plos Genetics|March 12, 2010
Rapid assessment of genetic ancestry in populations of unknown origin by genome-wide genotyping of pooled samplesCharleston W K Chiang, Zofia K Z Gajdos, Joshua M Korn, et al.
Journal of the National Cancer Institute|December 22, 2017
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer ImmunotherapyJodi A McKenzie, Rina M Mbofung, Shruti Malu, et al.
Medicine|October 6, 2023
Sodium and potassium consumption in Jamaica: National estimates and associated factors from the Jamaica Health and Lifestyle Survey 2016-2017Trevor S Ferguson, Novie O M Younger-Coleman, Karen Webster-Kerr, et al.
BMJ Open|December 10, 2023
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UKTimothy Simon Walsh, Leanne M Aitken, Cathrine A McKenzie, et al.
Nature Communications|September 8, 2017
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genesRina M Mbofung, Jodi A McKenzie, Shruti Malu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2018
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A ExpressionLu Huang, Shruti Malu, Jodi A McKenzie, et al.
Health Technology Assessment (Winchester, England)|July 1, 2026
Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluationTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2020
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicitySimone Punt, Shruti Malu, Jodi A McKenzie, et al.
American Journal of Human Genetics|January 15, 2013
LRIG2 mutations cause urofacial syndromeHelen M Stuart, Neil A Roberts, Berk Burgu, et al.
JAMA|May 19, 2025
Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical TrialTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
Pageof 74